Kovai Medical Center and Hospital Ltd Stock Price Today (NSE: KOVAI)
Fundamental Score
Kovai Medical Center and Hospital Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Kovai Medical Center and Hospital Ltd share price today is ₹5931.20, up +0.00% on NSE/BSE as of 2 January 2026. Kovai Medical Center and Hospital Ltd (KOVAI) is a Mid-cap company in the Hospital sector with a market capitalisation of ₹6.49K (Cr). The 52-week high for KOVAI share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 28.39x, KOVAI is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 21.23% and a debt-to-equity ratio of 0.34.
Kovai Medical Center and Hospital Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Kovai Medical Center and Hospital Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Kovai Medical Center and Hospital Share Price
The healthcare sector, particularly hospital chains, is currently experiencing a period of increased scrutiny due to rising operational costs and evolving regulatory landscapes. This analysis examines the financial stability of Kovai Medical Center and Hospital Ltd. Given the closing price of ₹5931.2, understanding the underlying financial metrics is crucial for investors. The assessment of the "Kovai Medical Center and Hospital share price" is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
One key metric is the Price-to-Earnings (PE) ratio of 28.39. This suggests that the market is valuing Kovai Medical Center and Hospital Ltd at a premium compared to its earnings, implying high growth expectations. However, it's essential to compare this valuation with its peers. While a deeper analysis of the management team at
Nephro Care India Limited is needed to fully assess comparative leadership quality, anecdotal evidence suggests investors should scrutinize management commentary and track record when assessing sector peers. A robust management team inspires confidence in navigating market uncertainties.The Return on Capital Employed (ROCE) of 23.31% is a positive indicator. It reveals how efficiently Kovai Medical Center and Hospital Ltd utilizes its capital to generate profits. A high ROCE like this can strengthen the company's economic moat, making it more difficult for competitors to erode its market share. This strong return on capital may allow for reinvestment into expansion, technology upgrades, or other strategic initiatives that can further solidify its competitive advantage and support long-term growth. Further investigation is required to determine the sustainability of this high ROCE.
Comparing Kovai Medical Center and Hospital Ltd. to sector peers such as Strategic Minerals Plc and Abateas Industries Ltd requires a deeper dive into each company’s specific operations, debt levels, and growth strategies. A comprehensive risk assessment would also consider macroeconomic factors, regulatory changes impacting the healthcare industry, and the company's ability to adapt to technological advancements in medical care. These observations are based solely on the publicly available financial data points presented.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Kovai Medical Center and Hospital Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of KOVAI across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (21.23%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (23.31%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (28.16%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 28.39 vs Industry: 52.84)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (14.01% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (17.18% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (17.18% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (9.50x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹510.73 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (56.52%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 6.14%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Kovai Medical Center and Hospital Ltd Financial Statements
Comprehensive financial data for Kovai Medical Center and Hospital Ltd including income statement, balance sheet and cash flow
About KOVAI (Kovai Medical Center and Hospital Ltd)
Kovai Medical Center and Hospital Ltd (KOVAI) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹6.49K (Cr). Kovai Medical Center and Hospital Ltd has delivered a Return on Equity (ROE) of 21.23% and a ROCE of 23.31%. The debt-to-equity ratio stands at 0.34, reflecting the company's capital structure. Investors tracking KOVAI share price can monitor key metrics including P/E ratio, promoter holding of 56.52%, and quarterly earnings growth.
Company Details
Key Leadership
Latest News
KOVAI Share Price: Frequently Asked Questions
What is the current share price of Kovai Medical Center and Hospital Ltd (KOVAI)?
As of 02 Jan 2026, 07:47 pm IST, Kovai Medical Center and Hospital Ltd share price is ₹5931.20. The KOVAI stock has a market capitalisation of ₹6.49K (Cr) on NSE/BSE.
Is KOVAI share price Overvalued or Undervalued?
KOVAI share price is currently trading at a P/E ratio of 28.39x, compared to the industry average of 52.84x. Based on this relative valuation, the Kovai Medical Center and Hospital Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of KOVAI share price?
The 52-week high of KOVAI share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Kovai Medical Center and Hospital Ltd share price?
Key factors influencing KOVAI share price include quarterly earnings growth (Sales Growth: 13.96%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Kovai Medical Center and Hospital Ltd a good stock for long-term investment?
Kovai Medical Center and Hospital Ltd shows a 5-year Profit Growth of 17.18% and an ROE of 21.23%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.34 before investing in KOVAI shares.
How does Kovai Medical Center and Hospital Ltd compare with its industry peers?
Kovai Medical Center and Hospital Ltd competes with major peers in the Hospital. Investors should compare KOVAI share price P/E of 28.39x and ROE of 21.23% against the industry averages to determine competitive standing.
What is the P/E ratio of KOVAI and what does it mean?
KOVAI share price has a P/E ratio of 28.39x compared to the industry average of 52.84x. Investors pay ₹28 for every ₹1 of annual earnings.
How is KOVAI performing according to Bull Run's analysis?
KOVAI has a Bull Run fundamental score of 67.1/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does KOVAI belong to?
KOVAI operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Kovai Medical Center and Hospital Ltd share price.
What is Return on Equity (ROE) and why is it important for KOVAI?
KOVAI has an ROE of 21.23%, which indicates excellent management efficiency. ROE measures how efficiently Kovai Medical Center and Hospital Ltd generates profits from shareholders capital.
How is KOVAI debt-to-equity ratio and what does it indicate?
KOVAI has a debt-to-equity ratio of 0.34, which indicates moderate leverage that should be monitored.
What is KOVAI dividend yield and is it a good dividend stock?
KOVAI offers a dividend yield of 0.17%, meaning you receive ₹0.17 annual dividend for every ₹100 invested in Kovai Medical Center and Hospital Ltd shares.
How has KOVAI share price grown over the past 5 years?
KOVAI has achieved 5-year growth rates of: Sales Growth 14.01%, Profit Growth 17.18%, and EPS Growth 17.18%.
What is the promoter holding in KOVAI and why does it matter?
Promoters hold 56.52% of KOVAI shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Kovai Medical Center and Hospital Ltd.
What is KOVAI market capitalisation category?
KOVAI has a market capitalisation of ₹6489 crores, placing it in the Mid-cap category.
How volatile is KOVAI stock?
KOVAI has a beta of N/A. A beta > 1 suggests the Kovai Medical Center and Hospital Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is KOVAI operating profit margin trend?
KOVAI has a 5-year average Operating Profit Margin (OPM) of 28.16%, indicating the company's operational efficiency.
How is KOVAI quarterly performance?
Recent quarterly performance shows Kovai Medical Center and Hospital Ltd YoY Sales Growth of 13.96% and YoY Profit Growth of 16.12%.
What is the institutional holding pattern in KOVAI?
KOVAI has FII holding of 1.25% and DII holding of 4.89%. Significant institutional holding often suggests professional confidence in the Kovai Medical Center and Hospital Ltd stock.